Tobias is currently investment manager at PMV. He serves on the boards of etherna, Rewind Therapeutics and Temmune Therapeutics. Prior to joining PMV, Tobias was active at the private equity department of BNP Paribas Fortis. Tobias holds a PhD in Biochemistry & Biotechnology from the KU Leuven.